Pathophysiology of atopic dermatitis

Clinics in Dermatology

Volumn 21, Issue 2, 2003, Pages 116-121

  Kang, Kefei ^a,b   Stevens, Seth R ^a,b,c  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Department of Dermatology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERMEDIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCITONIN GENE RELATED PEPTIDE; CD3 ANTIGEN; CD4 ANTIGEN; CYCLIC AMP PHOSPHODIESTERASE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HLA DR ANTIGEN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E RECEPTOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 13; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 5; LECTIN; LYMPHOCYTE ANTIGEN; NEUROPEPTIDE; SUBSTANCE P; VASCULAR CELL ADHESION MOLECULE 1; VASOACTIVE INTESTINAL POLYPEPTIDE;

ALLERGIC ASTHMA; ALLERGIC RHINITIS; ATOPIC DERMATITIS; BASOPHIL; CELL ACTIVITY; CELL FUNCTION; CELLULAR IMMUNITY; CHROMOSOME 14Q; CHROMOSOME 3Q; CHROMOSOME 5Q; CLINICAL FEATURE; CYTOKINE RELEASE; ENVIRONMENTAL FACTOR; EOSINOPHIL; FAMILY HISTORY; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC POLYMORPHISM; HEREDITY; HUMAN; IMMUNE SYSTEM; IMMUNOPATHOLOGY; IMMUNOREGULATION; INFECTION RISK; KERATINOCYTE; LANGERHANS CELL; LINKAGE ANALYSIS; LYMPHOCYTE; LYMPHOCYTIC INFILTRATION; MACROPHAGE FUNCTION; MAST CELL; MOLECULAR BIOLOGY; MONOCYTE; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RESPIRATORY TRACT ALLERGY; REVIEW; T LYMPHOCYTE ACTIVATION;

EID: 0037359045     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0738-081X(02)00361-9     Document Type: Review

References (36)

1. Uehara M., Kimura C. Descendant family history of atopic dermatitis. Acta Derm Venereol (Stockh). 73:1993;62-63.
2. Kang K.F., Tian R.M. Atopic dermatitis. An evaluation of clinical and laboratory findings. Int J Dermatol. 26:1987;27-32.
3. Diepgen T.L., Blettner M. Analysis of familial aggregation of atopic eczema and other atopic diseases by ODDS RATIO regression models. J Invest Dermatol. 106:1996;977-981.
4. Larsen F.S., Holm N.V., Henningsen K. Atopic dermatitis. A genetic-epidemiologic study in a population-based twin sample. J Am Acad Dermatol. 15:1986;487-494.
5. Agosti J.M., Sprenger J.D., Lum L.G., et al. Transfer of allergen-specific IgE-mediated hypersensitivity with allogeneic bone marrow transplantation. N Engl J Med. 319:1988;1623-1628.
6. Wollenberg A., Bieber T. Atopic dermatitis from the genes to skin lesions . Allergy. 55:2000;205-213.
7. Coleman R., Trembath R.C., Harper J.I. Genetic studies of atopy and atopic dermatitis. Br J Dermatol. 136:1997;1-5.
8. Lee Y.A., Wahn U., Kehrt R., et al. A major susceptibility locus for atopic dermatitis maps to chromosome 3q21. Nat Genet. 26:2000;470-473.
9. Cookson W.O., Ubhi B., Lawrence R., et al. Genetic linkage of childhood atopic dermatitis to psoriasis susceptibility loci. Nat Genet. 27:2001;372-373.
10. Sicherer S.H., Sampson H.A. Food hypersensitivity and atopic dermatitis pathophysiology, epidemiology, diagnosis, and management . J Allergy Clin Immunol. 104:1999;S114-122.
11. Valenta R., Seiberler S., Natter S., et al. Autoallergy a pathogenetic factor in atopic dermatitis? J Allergy Clin Immunol. 105:2000;432-437.
12. Leiferman K.M. A role for eosinophils in atopic dermatitis. J Am Acad Dermatol. 45:2001;S21-24.
13. Rees J., Friedmann P.S., Matthews J.N.S. Contact sensitivity to dinitrochlorobenzene is impaired in atopic subjects. Arch Dermatol. 126:1990;1173-1175.
14. Grewe M., Bruijnzeel-Koomen C.A.F.M., Schopf E., et al. A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol Today. 19:1998;359-361.
15. Akdis C.A., Akdis M., Trautmann A., Blaser K. Immune regulation in atopic dermatitis. Curr Opin Immunol. 12:2000;641-646.
16. Wollenberg A., Kraft S., Hanau D., Bieber T. Immunomorphological and ultrastructural characterization of Langerhans cells and a novel, inflammatory dendritic epidermal cell (IDEC) population in lesional skin of atopic eczema. J Invest Dermatol. 106:1996;446-453.
17. + Langerhans cells are responsible for increased autologous T lymphocyte reactivity to lesional epidermal cells of patients with atopic dermatitis. J Immunol. 147:1991;3794-3802.
18. Valenta R., Maurer D., Steiner R., et al. Immunoglobulin E response to human proteins in atopic patients. J Invest Dermatol. 107:1996;203-208.
19. Bieber T. FcεRI-expressing antigen-presenting cells new players in the atopic game . J Immunol. 159:1997;599-605.
20. Dworzak M.N., Froschl G., Printz D., et al. Skin-associated lymphocytes in the peripheral blood of patients with atopic dermatitis signs of subset expansion and stimulation . J Allergy Clin Immunol. 103:1999;901-906.
21. Leung D.Y.M., Gately M., Trumble A., et al. Bacterial superantigens induce T cell expression of the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen, via stimulation of interleukin 12 production. J Exp Med. 181:1995;747-753.
22. Parronchi P., Macchia D., Piccinni M.P., et al. Allergen- and bacterial antigen-specific T-cell clones established from atopic donors show a different profile of cytokine production. Proc Natl Acad Sci USA. 88:1991;4538-4542.
23. Kanda N., Watanabe S. Intracellular 3′, 5′-adenosine cyclic monophosphate level regulates house dust mite-induced interleukin-13 production by T cells from mite-sensitive patients with atopic dermatitis. J Invest Dermatol. 116:2001;3-11.
24. Jirapongsananuruk O., Hofer M.F., Trumble A.E., et al. Enhanced expression of B7.2 (CD86) in patients with atopic dermatitis a potential role in the modulation of IgE synthesis . J Immunol. 160:1998;4622-4627.
25. Pastore S., Corinti S., La Placa M., et al. Interferon-gamma promotes exaggerated cytokine production in keratinocytes cultured from patients with atopic dermatitis. J Allergy Clin Immunol. 101:1998;538-544.
26. + T cell infiltration with increased IL-16 gene expression in atopic dermatitis. J Allergy Clin Immunol. 102:1998;645-650.
27. Grewe M., Czech W., Morita A., et al. Human eosinophils produce biologically active IL-12 implications for control of T cell responses . J Immunol. 161:1998;415-420.
28. Butler J.M., Chan S.C., Stevens D.R., Hanifin J.M. Increased leukocyte histamine release with elevated cyclic AMP-phosphodiesterase activity in atopic dermatitis. J Allergy Clin Immunol. 71:1983;490-497.
29. Gauchat J.F., Henchoz S., Mazzei G., et al. Induction of human IgE synthesis in B cells by mast cells and basophils. Nature. 365:1993;340-343.
30. + lymphocytes into lesional atopic dermatitis skin. J Invest Dermatol. 115:2000;640-646.
31. Nakayama T., Fujisawa R., Yamada H., et al. Inducible expression of a CC chemokine liver- and activation-regulated chemokine (LARC)/macrophage inflammatory protein (MIP)-3 α/CCL20 by epidermal keratinocytes and its role in atopic dermatitis. Int Immunol. 13:2001;95-103.
32. Hanifin J.M., Chan S. Biochemical and immunologic mechanisms in atopic dermatitis new targets for emerging therapies . J Am Acad Dermatol. 41:1999;72-77.
33. Scholzen T., Armstrong C.A., Bunnett N.W., et al. Neuropeptides in the skin interactions between the neuroendocrine and the skin immune systems . Exp Dermatol. 7:1998;81-96.
34. Giannetti A. Neuropeptides in atopic dermatitis. Curr Probl Dermatol. 28:1999;51-55.
35. Hara J., Higuchi K., Okamoto R., et al. High-expression of sphingomyelin deacylase is an important determinant of ceramide deficiency leading to barrier disruption in atopic dermatitis. J Invest Dermatol. 115:2000;406-413.
36. Kondo H., Ichikawa Y., Imokawa G. Percutaneous sensitization with allergens through barrier-disrupted skin elicits a Th2-dominant cytokine response. Eur J Immunol. 28:1998;769-779.